BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21135555)

  • 1. Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer's disease cases.
    O'Bryant SE; Hobson VL; Hall JR; Barber RC; Zhang S; Johnson L; Diaz-Arrastia R;
    Dement Geriatr Cogn Disord; 2011; 31(1):31-6. PubMed ID: 21135555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor levels in Alzheimer's disease.
    O'Bryant SE; Hobson V; Hall JR; Waring SC; Chan W; Massman P; Lacritz L; Cullum CM; Diaz-Arrastia R;
    J Alzheimers Dis; 2009; 17(2):337-41. PubMed ID: 19363274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage-dependent BDNF serum concentrations in Alzheimer's disease.
    Laske C; Stransky E; Leyhe T; Eschweiler GW; Wittorf A; Richartz E; Bartels M; Buchkremer G; Schott K
    J Neural Transm (Vienna); 2006 Sep; 113(9):1217-24. PubMed ID: 16362629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study.
    Komulainen P; Pedersen M; Hänninen T; Bruunsgaard H; Lakka TA; Kivipelto M; Hassinen M; Rauramaa TH; Pedersen BK; Rauramaa R
    Neurobiol Learn Mem; 2008 Nov; 90(4):596-603. PubMed ID: 18707012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF.
    Lim YY; Rainey-Smith S; Lim Y; Laws SM; Gupta V; Porter T; Bourgeat P; Ames D; Fowler C; Salvado O; Villemagne VL; Rowe CC; Masters CL; Zhou XF; Martins RN; Maruff P
    Int Psychogeriatr; 2017 Nov; 29(11):1825-1834. PubMed ID: 28720165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis.
    Ng TKS; Ho CSH; Tam WWS; Kua EH; Ho RC
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels.
    Angelucci F; Spalletta G; di Iulio F; Ciaramella A; Salani F; Colantoni L; Varsi AE; Gianni W; Sancesario G; Caltagirone C; Bossù P
    Curr Alzheimer Res; 2010 Feb; 7(1):15-20. PubMed ID: 20205668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression.
    Pláteník J; Fišar Z; Buchal R; Jirák R; Kitzlerová E; Zvěřová M; Raboch J
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():83-93. PubMed ID: 24334212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.
    Kim BY; Lee SH; Graham PL; Angelucci F; Lucia A; Pareja-Galeano H; Leyhe T; Turana Y; Lee IR; Yoon JH; Shin JI
    Mol Neurobiol; 2017 Nov; 54(9):7297-7311. PubMed ID: 27815832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum brain-derived neurotrophic factor levels as a predictor for Alzheimer disease progression.
    Tsai MJ; Lin YS; Chen CY; Lee WJ; Fuh JL
    J Chin Med Assoc; 2023 Nov; 86(11):960-965. PubMed ID: 37713318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Environmental Correlates of Serum BDNF: A Descriptive Study with Plausible Implications for AD Research.
    Weinstein G; Preis SR; Beiser AS; Kaess B; Chen TC; Satizabal C; Rahman F; Benjamin EJ; Vasan RS; Seshadri S
    Curr Alzheimer Res; 2017; 14(7):722-730. PubMed ID: 28164772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment.
    Gezen-Ak D; Dursun E; Hanağası H; Bilgiç B; Lohman E; Araz ÖS; Atasoy IL; Alaylıoğlu M; Önal B; Gürvit H; Yılmazer S
    J Alzheimers Dis; 2013; 37(1):185-95. PubMed ID: 23948885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia.
    Yasutake C; Kuroda K; Yanagawa T; Okamura T; Yoneda H
    Eur Arch Psychiatry Clin Neurosci; 2006 Oct; 256(7):402-6. PubMed ID: 16783499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
    Stringham NT; Holmes PV; Stringham JM
    Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression--a preliminary report.
    Grassi-Oliveira R; Stein LM; Lopes RP; Teixeira AL; Bauer ME
    Biol Psychiatry; 2008 Aug; 64(4):281-5. PubMed ID: 18406398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study.
    Weinstein G; Beiser AS; Choi SH; Preis SR; Chen TC; Vorgas D; Au R; Pikula A; Wolf PA; DeStefano AL; Vasan RS; Seshadri S
    JAMA Neurol; 2014 Jan; 71(1):55-61. PubMed ID: 24276217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects.
    Li G; Peskind ER; Millard SP; Chi P; Sokal I; Yu CE; Bekris LM; Raskind MA; Galasko DR; Montine TJ
    PLoS One; 2009; 4(5):e5424. PubMed ID: 19412541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute aerobic exercise increases brain-derived neurotrophic factor levels in elderly with Alzheimer's disease.
    Coelho FG; Vital TM; Stein AM; Arantes FJ; Rueda AV; Camarini R; Teodorov E; Santos-Galduróz RF
    J Alzheimers Dis; 2014; 39(2):401-8. PubMed ID: 24164734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment and BDNF serum levels.
    Siuda J; Patalong-Ogiewa M; Żmuda W; Targosz-Gajniak M; Niewiadomska E; Matuszek I; Jędrzejowska-Szypułka H; Lewin-Kowalik J; Rudzińska-Bar M
    Neurol Neurochir Pol; 2017; 51(1):24-32. PubMed ID: 28341039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.
    Laske C; Stransky E; Leyhe T; Eschweiler GW; Maetzler W; Wittorf A; Soekadar S; Richartz E; Koehler N; Bartels M; Buchkremer G; Schott K
    J Psychiatr Res; 2007 Aug; 41(5):387-94. PubMed ID: 16554070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.